Literature DB >> 990216

Plasma levels of pregnancy-specific beta1-glycoprotein in normal pregnancy.

C M Towler, C H Horne, V Jandial, D M Campbell, I MacGillivray.   

Abstract

Pregnancy-specific beta-glycoprotein (PSbetaG) is a major product of the trophoblast which has only recently been identified. Like human placental lactogen, the concentration of PSbetaG in maternal blood rises throughout pregnancy until about 34 weeks, thereafter tending to remain constant until term, with only a small day-to-day variation in individuals. The circulating maternal levels of PSbetaG between 34 weeks and term are about 200 mug/ml, 20 to 30 times greater than the levels of placental lactogen, thus allowing detection and measurement of PSbetaG by relatively simple techniques. The levels of PSbetaG are above the normal range in the majority of twin pregnancies. It is suggested that PSbetaG measurements may be useful in assessing placental function and may help in the detection of multiple pregnancies at an early stage of gestation.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 990216     DOI: 10.1111/j.1471-0528.1976.tb00743.x

Source DB:  PubMed          Journal:  Br J Obstet Gynaecol        ISSN: 0306-5456


  10 in total

1.  Pregnancy-specific glycoprotein expression in normal gastrointestinal tract and in tumors detected with novel monoclonal antibodies.

Authors:  Aileen Houston; John M Williams; Tihana Lenac Rovis; Daniel K Shanley; Ronan T O'Riordan; Patrick A Kiely; Melanie Ball; Orla P Barry; Jacquie Kelly; Aine Fanning; John MacSharry; Ofer Mandelboim; Bernhard B Singer; Stipan Jonjic; Tom Moore
Journal:  MAbs       Date:  2016-02-29       Impact factor: 5.857

2.  Pro-angiogenic effects of pregnancy-specific glycoproteins in endothelial and extravillous trophoblast cells.

Authors:  Shemona Rattila; Florian Kleefeldt; Angela Ballesteros; Jimena S Beltrame; Maria L Ribeiro; Süleyman Ergün; Gabriela Dveksler
Journal:  Reproduction       Date:  2020-11       Impact factor: 3.906

3.  Detection of pregnancy specific protein SP-1 by enzyme immunoassay in early pregnancy.

Authors:  G Tatra; P Kemeter
Journal:  Arch Gynecol       Date:  1983

4.  Glycan characterization of pregnancy-specific glycoprotein 1 and its identification as a novel Galectin-1 ligand.

Authors:  Mirian Mendoza; Dongli Lu; Angela Ballesteros; Sandra M Blois; Kelsey Abernathy; Chiguang Feng; Charles J Dimitroff; Jonathan Zmuda; Maria Panico; Anne Dell; Gerardo R Vasta; Stuart M Haslam; Gabriela Dveksler
Journal:  Glycobiology       Date:  2020-10-21       Impact factor: 4.313

5.  Concentrations of placental proteins (HPL and SP1) in maternal serum throughout normal pregnancy.

Authors:  M P Baur; O Bellmann; J Tebbe; N Lang
Journal:  Arch Gynecol       Date:  1982

6.  Pregnancy Specific β-1 Glycoprotein 1 is Expressed in Pancreatic Ductal Adenocarcinoma and its Subcellular Localization Correlates with Overall Survival.

Authors:  Jasmin H Shahinian; Hannah Fuellgraf; Stefan Tholen; Justin Mastroianni; Julia Daniela Knopf; Markus Kuehs; Bettina Mayer; Manuel Schlimpert; Birte Kulemann; Simon Kuesters; Jens Hoeppner; Ulrich F Wellner; Martin Werner; Ulrich T Hopt; Robert Zeiser; Peter Bronsert; Oliver Schilling
Journal:  J Cancer       Date:  2016-10-17       Impact factor: 4.207

7.  Pregnancy-specific glycoprotein 9 acts as both a transcriptional target and a regulator of the canonical TGF-β/Smad signaling to drive breast cancer progression.

Authors:  Ying-Ying Liu; Sa Zhang; Tian-Jian Yu; Fang-Lin Zhang; Fan Yang; Yan-Ni Huang; Ding Ma; Guang-Yu Liu; Zhi-Ming Shao; Da-Qiang Li
Journal:  Clin Transl Med       Date:  2020-12

8.  Pregnancy-specific glycoproteins bind integrin αIIbβ3 and inhibit the platelet-fibrinogen interaction.

Authors:  Daniel K Shanley; Patrick A Kiely; Kalyan Golla; Seamus Allen; Kenneth Martin; Ronan T O'Riordan; Melanie Ball; John D Aplin; Bernhard B Singer; Noel Caplice; Niamh Moran; Tom Moore
Journal:  PLoS One       Date:  2013-02-28       Impact factor: 3.240

9.  Recombinant Pregnancy-Specific Glycoprotein 1 Has a Protective Role in a Murine Model of Acute Graft-versus-Host Disease.

Authors:  Karlie Jones; Sarah Bryant; Jian Luo; Patricia Kiesler; Sherry Koontz; James Warren; Harry Malech; Elizabeth Kang; Gabriela Dveksler
Journal:  Biol Blood Marrow Transplant       Date:  2018-09-22       Impact factor: 5.609

10.  PSG9 Stimulates Increase in FoxP3+ Regulatory T-Cells through the TGF-β1 Pathway.

Authors:  Karlie Jones; Angela Ballesteros; Margaret Mentink-Kane; James Warren; Shemona Rattila; Harry Malech; Elizabeth Kang; Gabriela Dveksler
Journal:  PLoS One       Date:  2016-07-07       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.